Dietary saturate/unsaturate ratio as a determinant of adiposity

Medical Hypotheses

Volumn 75, Issue 1, 2010, Pages 14-16

  McCarty, Mark F ^a  

^a NutriGuard Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CERAMIDE; DIACYLGLYCEROL; INSULIN; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; SATURATED FATTY ACID; SOMATOMEDIN C RECEPTOR; UNSATURATED FATTY ACID;

ARTICLE; BODY MASS; DIETARY INTAKE; FAT INTAKE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; MEDITERRANEAN DIET; OBESITY; PANCREAS SECRETION; PREDICTION; REGULATORY MECHANISM; UPREGULATION; VEGETARIAN DIET;

ADIPOSITY; DIETARY FATS; DIETARY FATS, UNSATURATED; HUMANS; INSULIN; INSULIN RESISTANCE;

EID: 77953361525     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.12.021     Document Type: Article

References (74)

1. Haddad E.H., Berk L.S., Kettering J.D., Hubbard R.W., Peters W.R. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am J Clin Nutr 1999, 70(3 Suppl.):586S-593S.
2. Toohey M.L., Harris M.A., DeWitt W., Foster G., Schmidt W.D., Melby C.L. Cardiovascular disease risk factors are lower in African-American vegans compared to lacto-ovo-vegetarians. J Am Coll Nutr 1998, 17(5):425-434.
3. Spencer E.A., Appleby P.N., Davey G.K., Key T.J. Diet and body mass index in 38000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans. Int J Obes Relat Metab Disord 2003, 27(6):728-734.
4. Newby P.K., Tucker K.L., Wolk A. Risk of overweight and obesity among semivegetarian, lactovegetarian, and vegan women. Am J Clin Nutr 2005, 81(6):1267-1274.
5. Waldmann A., Koschizke J.W., Leitzmann C., Hahn A. German vegan study: diet, life-style factors, and cardiovascular risk profile. Ann Nutr Metab 2005, 49(6):366-372.
6. Key T.J., Appleby P.N., Rosell M.S. Health effects of vegetarian and vegan diets. Proc Nutr Soc 2006, 65(1):35-41.
7. Tonstad S., Butler T., Yan R., Fraser G.E. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes. Diabetes Care 2009, 32(5):791-796.
8. Trichopoulou A., Naska A., Orfanos P., Trichopoulos D. Mediterranean diet in relation to body mass index and waist-to-hip ratio: the Greek European Prospective Investigation into Cancer and Nutrition Study. Am J Clin Nutr 2005, 82(5):935-940.
9. Panagiotakos D.B., Chrysohoou C., Pitsavos C., Stefanadis C. Association between the prevalence of obesity and adherence to the Mediterranean diet: the ATTICA study. Nutrition 2006, 22(5):449-456.
10. Shubair M.M., McColl R.S., Hanning R.M. Mediterranean dietary components and body mass index in adults: the peel nutrition and heart health survey. Chronic Dis Can 2005, 26(2-3):43-51.
11. Schroder H., Marrugat J., Vila J., Covas M.I., Elosua R. Adherence to the traditional mediterranean diet is inversely associated with body mass index and obesity in a spanish population. J Nutr 2004, 134(12):3355-3361.
12. Rosell M., Appleby P., Spencer E., Key T. Weight gain over 5 years in 21, 966 meat-eating, fish-eating, vegetarian, and vegan men and women in EPIC-Oxford. Int J Obes (Lond) 2006, 30(9):1389-1396.
13. Mendez M.A., Popkin B.M., Jakszyn P., Berenguer A., Tormo M.J., Sanchez M.J., et al. Adherence to a Mediterranean diet is associated with reduced 3-year incidence of obesity. J Nutr 2006, 136(11):2934-2938.
14. Sanchez-Villegas A., Bes-Rastrollo M., Martinez-Gonzalez M.A., Serra-Majem L. Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int J Obes (Lond) 2006, 30(2):350-358.
15. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40(2):280-289.
16. Chavez J.A., Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 2003, 419(2):101-109.
17. Schmitz-Peiffer C., Craig D.L., Biden T.J. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999, 274(34):24202-242010.
18. Sabin M.A., Stewart C.E., Crowne E.C., Turner S.J., Hunt L.P., Welsh G.I., et al. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol 2007, 211(1):244-252.
19. Maron D.J., Fair J.M., Haskell W.L. Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff. Circulation 1991, 84(5):2020-2027.
20. Parker D.R., Weiss S.T., Troisi R., Cassano P.A., Vokonas P.S., Landsberg L. Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. Am J Clin Nutr 1993, 58(2):129-136.
21. Pickersgill L., Litherland G.J., Greenberg A.S., Walker M., Yeaman S.J. Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 2007, 282(17):12583-12589.
22. Lee J.S., Pinnamaneni S.K., Eo S.J., Cho I.H., Pyo J.H., Kim C.K., et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 2006, 100(5):1467-1474.
23. Galgani J.E., Uauy R.D., Aguirre C.A., Diaz E.O. Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 2008, 100(3):471-479.
24. Riserus U. Fatty acids and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2008, 11(2):100-105.
25. Riserus U., Willett W.C., Hu F.B. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009, 48(1):44-51.
26. Bergouignan A, Momken I, Schoeller DA, Simon C, Blanc S. Metabolic fate of saturated and monounsaturated dietary fats: the Mediterranean diet revisited from epidemiological evidence to cellular mechanisms. Prog Lipid Res 2009.
27. Cases S., Stone S.J., Zhou P., Yen E., Tow B., Lardizabal K.D., et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 2001, 276(42):38870-38876.
28. Sarkkinen E., Schwab U., Niskanen L., Hannuksela M., Savolainen M., Kervinen K., et al. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. Eur J Clin Nutr 1996, 50(9):592-598.
29. Louheranta A.M., Sarkkinen E.S., Vidgren H.M., Schwab U.S., Uusitupa M.I. Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance. Am J Clin Nutr 2002, 76(2):331-337.
30. Dimopoulos N., Watson M., Sakamoto K., Hundal H.S. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J 2006, 399(3):473-481.
31. Hermansen K., Mortensen L.S. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus. Drug Safety 2007, 30(12):1127-1142.
32. Pi-Sunyer F.X. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight. Postgrad Med 2008, 120(2):5-17.
33. Piers L.S., Walker K.Z., Stoney R.M., Soares M.J., O'Dea K. Substitution of saturated with monounsaturated fat in a 4-week diet affects body weight and composition of overweight and obese men. Br J Nutr 2003, 90(3):717-727.
34. Ornish D., Brown S.E., Scherwitz L.W., Billings J.H., Armstrong W.T., Ports T.A., et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990, 336(8708):129-133. JID - 2985213R.
35. Ornish D. Eat more, weigh less: Dr. Dean Ornish's Life Choice Program for losing weight safely while eating abundantly 1997, Harper, New York.
36. Nicholson A.S., Sklar M., Barnard N.D., Gore S., Sullivan R., Browning S. Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med 1999, 29(2):87-91.
37. Turner-McGrievy G.M., Barnard N.D., Scialli A.R. A two-year randomized weight loss trial comparing a vegan diet to a more moderate low-fat diet. Obesity (Silver Spring) 2007, 15(9):2276-2281.
38. Barnard R.J., Ugianskis E.J., Martin D.A., Inkeles S.B. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992, 69(5):440-444.
39. McDougall J.A. The McDougall Program for maximum weight loss 1994, Dutton, New York.
40. Jones P.J., Pencharz P.B., Clandinin M.T. Whole body oxidation of dietary fatty acids: implications for energy utilization. Am J Clin Nutr 1985, 42(5):769-777.
41. Piers L.S., Walker K.Z., Stoney R.M., Soares M.J., O'Dea K. The influence of the type of dietary fat on postprandial fat oxidation rates: monounsaturated (olive oil) vs. saturated fat (cream). Int J Obes Relat Metab Disord 2002, 26(6):814-821.
42. Kien C.L., Bunn J.Y., Ugrasbul F. Increasing dietary palmitic acid decreases fat oxidation and daily energy expenditure. Am J Clin Nutr 2005, 82(2):320-326.
43. Schroder H. Protective mechanisms of the Mediterranean diet in obesity and type 2 diabetes. J Nutr Biochem 2007, 18(3):149-160.
44. Bell E.A., Castellanos V.H., Pelkman C.L., Thorwart M.L., Rolls B.J. Energy density of foods affects energy intake in normal-weight women. Am J Clin Nutr 1998, 67(3):412-420.
45. Bell E.A., Rolls B.J. Energy density of foods affects energy intake across multiple levels of fat content in lean and obese women. Am J Clin Nutr 2001, 73(6):1010-1018.
46. Stookey J.D. Energy density, energy intake and weight status in a large free-living sample of Chinese adults: exploring the underlying roles of fat, protein, carbohydrate, fiber and water intakes. Eur J Clin Nutr 2001, 55(5):349-359.
47. Dietschy J.M. Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations. J Nutr 1998, 128(2 Suppl):444S-448S.
48. Sacks F.M., Castelli W.P., Donner A., Kass E.H. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med 1975, 292(22):1148-1151.
49. Resnicow K., Barone J., Engle A., Miller S., Haley N.J., Fleming D., et al. Diet and serum lipids in vegan vegetarians: a model for risk reduction. J Am Diet Assoc 1991, 91(4):447-453.
50. Hopkins P.N. Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. Am J Clin Nutr 1992, 55(6):1060-1070.
51. Carroll K.K. Hypercholesterolemia and atherosclerosis: effects of dietary protein. Fed Proc 1982, 41(11):2792-2796.
52. Kurowska E.M., Carroll K.K. Effect of high levels of selected dietary essential amino acids on hypercholesterolemia and down-regulation of hepatic LDL receptors in rabbits. Biochim Biophys Acta 1992, 1126(2):185-191.
53. Sanchez A., Hubbard R.W. Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses 1991, 35(4):324-329.
54. McCarty M.F., Barroso-Aranda J., Contreras F. The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. Med Hypotheses 2009, 72(2):125-128.
55. Underwood L.E., Thissen J.P., Lemozy S., Ketelslegers J.M., Clemmons D.R. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994, 42(4-5):145-151.
56. Straus D.S. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J 1994, 8(1):6-12.
57. Allen N.E., Appleby P.N., Davey G.K., Key T.J. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer 2000, 83(1):95-97.
58. Allen N.E., Appleby P.N., Davey G.K., Kaaks R., Rinaldi S., Key T.J. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 2002, 11(11):1441-1448.
59. Jacobs R.L., Stead L.M., Brosnan M.E., Brosnan J.T. Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver. J Biol Chem 2001, 276(47):43740-43747.
60. Baxter R.C. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994, 42(4-5):140-144.
61. Lewitt M.S., Denyer G.S., Cooney G.J., Baxter R.C. Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 1991, 129(4):2254-2256.
62. Frystyk J., Hussain M., Skjaerbaek C., Schmitz O., Christiansen J.S., Froesch E.R., et al. Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline. Am J Physiol 1997, 273(3 Pt. 1):E507-E513.
63. Jousse C., Bruhat A., Ferrara M., Fafournoux P. Physiological concentration of amino acids regulates insulin-like- growth-factor-binding protein 1 expression. Biochem J 1998, 334(Pt. 1):147-153.
64. Franks S., Kiddy D.S., Hamilton-Fairley D., Bush A., Sharp P.S., Reed M.J. The role of nutrition and insulin in the regulation of sex hormone binding globulin. J Steroid Biochem Mol Biol 1991, 39(5B):835-838.
65. Reis A.F., Miranda W.L., Chacra A.R. Low levels of sex hormone-binding globulin and hyperproinsulinemia as markers of increased pancreatic beta-cell demand in men. Braz J Med Biol Res 1998, 31(12):1545-1551.
66. Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000, 92(18):1472-1489.
67. Moschos S.J., Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 2002, 63(4):317-332.
68. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995, 6(2):164-179.
69. Hiney J.K., Srivastava V., Nyberg C.L., Ojeda S.R., Dees W.L. Insulin-like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 1996, 137(9):3717-3728.
70. Sanchez A., Kissinger D.G., Phillips R.I. A hypothesis on the etiological role of diet on age of menarche. Med Hypotheses 1981, 7(11):1339-1345.
71. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003, 35(11-12):694-704.
72. McCarty M.F. Insulin and IGF-I as determinants of low " Western" cancer rates in the rural third world. Int J Epidemiol 2004, 33(4):908-910.
73. Campbell TC, Campbell TM. The China study: the most comprehensive study of nutrition ever conducted and the startling implications for diet, weight Loss and long-term health. Benbella Books; 2006.
74. Barnard R.J. Prevention of cancer through lifestyle changes. Evid Based Complement Alternat Med 2004, 1(3):233-239.